Patheon expands in U.K.; Merck KGaA talks Quintiles deal;

> Patheon is expanding its contract manufacturing capabilities at its Milton Park, U.K., facility. News

> Outsourcing-Pharma sat down with Merck KGaA leadership to discuss the drugmaker's deep-seated deal with Quintiles ($Q). Story

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.